MR-based hypoxia measures in human glioma.

Area of Science:

• Neuroimaging
• Oncology
• Medical Physics

Background:

• Hypoxia is a key factor in malignant tumor development, therapy resistance, and radio-insensitivity.
• Accurate hypoxia imaging is vital for diagnosing brain tumors and guiding treatment.
• Current imaging methods may not fully capture the metabolic state related to tumor aggressiveness.

Purpose of the Study:

• To evaluate a novel Blood Oxygen Level-Dependent (BOLD)-based MRI technique for measuring relative oxygen extraction fraction (rOEF) in glioma patients.
• To assess the diagnostic potential and limitations of rOEF mapping in differentiating tumor grades and identifying hypoxic regions.
• To correlate MRI findings with histological markers of hypoxia.

Main Methods:

• A pilot study involving 45 glioma patients using a 3T MR scanner.
• Quantitative BOLD approach to calculate rOEF from T2, T2*, and cerebral blood volume (CBV) measurements.
• Visual and volumetric analysis of rOEF maps, with histological correlation using HIF-1α-immunohistochemistry in a subset of patients.

Main Results:

• Diagnostic quality rOEF maps were successfully obtained.
• High rOEF values, indicative of hypoxia, were prevalent in high-grade gliomas but absent in low-grade tumors.
• Hypoxic regions were identified in both contrast-enhancing and non-enhancing tumor areas.
• Potential biases in CBV measurements due to contrast agent leakage and susceptibility effects were noted.
• Histology showed a reasonable correlation between MRI characteristics and HIF-1α staining.

Conclusions:

• The novel rOEF imaging method shows promise for metabolic characterization of human gliomas.
• Confounding factors, particularly related to CBV measurement in the presence of contrast leakage, require careful consideration for accurate rOEF interpretation.
• Further validation with larger cohorts and extended immunohistochemical analysis is necessary.